Ardsley Advisory Partners’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Ardsley Advisory Partners’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-15,000	Closed	-$156K	–	210
2020 Q3	$156K	Sell	15,000 -10,000	-40%	-$123K	0.03%	132
2020 Q2	$329K	Buy	+25,000	New	+$259K	0.07%	99
2018 Q4	–	Sell	-415,000	Closed	-$7.76M	–	178
2018 Q3	$7.76M	Sell	415,000 -180,000	-30%	-$4.14M	1.05%	29
2018 Q2	$15.4M	Buy	595,000 +75,000	+14%	+$1.95M	2.31%	12
2018 Q1	$11.7M	Buy	520,000 +105,000	+25%	+$2.56M	1.75%	20
2017 Q4	$10.4M	Buy	415,000 +240,000	+137%	+$5.88M	1.26%	25
2017 Q3	$4.23M	Buy	175,000 +10,000	+6%	+$235K	0.56%	53
2017 Q2	$3.34M	Buy	+165,000	New	+$3.44M	0.52%	56

Other funds holding FLXN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

Ardsley Advisory Partners's FLXN Position: Q4 2020 in Review

Ardsley Advisory Partners sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2020, closing a stake of 15,000 shares — an estimated $156K sold.

Ardsley Advisory Partners first reported a position in FLXN in Q2 2017 and held it in 8 quarters. The position peaked at $15.4M in Q2 2018. 141 funds tracked by Wall St. Rank hold FLXN as of Q4 2020.

Ardsley Advisory Partners reported no remaining Flexion Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
Ardsley Advisory Partners sold 15,000 Flexion Therapeutics, Inc. shares in Q4 2020, an estimated $156K.
Ardsley Advisory Partners first reported a position in Flexion Therapeutics, Inc. in Q2 2017 and held it in 8 quarters.
Ardsley Advisory Partners's Flexion Therapeutics, Inc. position peaked at $15.4M in Q2 2018.
141 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2020.

Based on Ardsley Advisory Partners's 13F filing for Q4 2020, filed 16 Feb 2021.